Remove Heart Disease Remove Pediatrics Remove Ultrasound
article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.

article thumbnail

New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

DAIC

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer. In structural heart disease, the quality of a 3D TEE image can help save lives.

article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

article thumbnail

Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease

DAIC

Getty Images milla1cf Tue, 01/16/2024 - 14:11 January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.

article thumbnail

Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story

Conquering CHD

Zeke and Zane were both diagnosed with hypoplastic left heart syndrome (HLHS) before birth. As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. The Heart Institute collaborates with the CFCC through the Fetal Cardiology Program.

article thumbnail

What is Ultrafast Ultrasound Imaging?

All About Cardiovascular System and Disorders

Ultrasound techniques currently used in echocardiography uses frame rates from 30-150 frames/s. This limits its temporal resolution for very short lived events, especially in pediatric and congenital heart disease with faster heart rates compared to adults [1]. J Am Coll Cardiol. 2024 Jan 2;83(1):63-81.

article thumbnail

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

DAIC

This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.